References
- Smith SM, Dart RC, Katz NP, et al. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain. 2013;154(11):2287–2296. doi:https://doi.org/10.1016/j.pain.2013.05.053.
- SAMHSA. Key Substance Use and Mental Health Indicators in the United States: Results from the 2016 National Survey on Drug Use and Health. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2017. https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHNationalFindingsReport2018/NSDUHNationalFindingsReport2018.pdf.
- Zale EL, Dorfman ML, Hooten WM, Warner DO, Zvolensky MJ, Ditre JW. Tobacco smoking, nicotine dependence, and patterns of prescription opioid misuse: results from a nationally representative sample. NICTOB. 2015;17(9):1096–1103. doi:https://doi.org/10.1093/ntr/ntu227.
- Merrill JO, Von Korff M, Banta-Green CJ, et al. Prescribed opioid difficulties, depression and opioid dose among chronic opioid therapy patients. Gen Hosp Psychiatry. 2012;34(6):581–587. doi:https://doi.org/10.1016/j.genhosppsych.2012.06.018.
- Scherrer JF, Salas J, Copeland LA, et al. Increased risk of depression recurrence after initiation of prescription opioids in noncancer pain patients. J Pain. 2016;17(4):473–482. doi:https://doi.org/10.1016/j.jpain.2015.12.012.
- Morasco BJ, Turk DC, Donovan DM, Dobscha SK. Risk for prescription opioid misuse among patients with a history of substance use disorder. Drug Alcohol Depend. 2013;127(1-3):193–199. doi:https://doi.org/10.1016/j.drugalcdep.2012.06.032.
- Abuse NI on D. Pain and Opiophobia. Research Report Series-Prescription Drugs: Abuse and Addiction. http://www.nida.nih.gov/ResearchReports/Prescription/Prescription6a.html. Published 2010.
- Boscarino JA, Rukstalis MR, Hoffman SN, et al. Prevalence of prescription opioid-use disorder among chronic pain patients: comparison of the DSM-5 vs. DSM-4 diagnostic criteria. J Addict Dis. 2011;30(3):185–194. doi:https://doi.org/10.1080/10550887.2011.581961.
- Compton WM, Volkow ND. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend. 2006;81(2):103–107. doi:https://doi.org/10.1016/j.drugalcdep.2005.05.009.
- Gilson AM, Ryan KM, Joranson DE, Dahl JL. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997–2002. J Pain Symptom Manage. 2004;28(2):176–188. doi:https://doi.org/10.1016/j.jpainsymman.2004.01.003.
- Voon P, Karamouzian M, Kerr T. Chronic pain and opioid misuse: a review of reviews. Subst Abuse Treat Prev Policy. 2017;12(1):36. doi:https://doi.org/10.1186/s13011-017-0120-7.
- Katz C, El-Gabalawy R, Keyes KM, Martins SS, Sareen J. Risk factors for incident nonmedical prescription opioid use and abuse and dependence: results from a longitudinal nationally representative sample. Drug Alcohol Depend. 2013;132(1-2):107–113. doi:https://doi.org/10.1016/j.drugalcdep.2013.01.010.
- Dobscha SK, Morasco BJ, Duckart JP, Macey T, Deyo RA. Correlates of prescription opioid initiation and long-term opioid use in veterans with persistent pain. Clin J Pain. 2013;29(2):102–108. doi:https://doi.org/10.1097/AJP.0b013e3182490bdb.
- Hah JM, Sturgeon JA, Zocca J, Sharifzadeh Y, Mackey SC. Factors associated with prescription opioid misuse in a cross-sectional cohort of patients with chronic non-cancer pain. JPR. 2017;10:979–987. doi:https://doi.org/10.2147/JPR.S131979.
- Chun J, Haug NA, Guydish JR, Sorensen JL, Delucchi K. Cigarette smoking among opioid-dependent clients in a therapeutic community. Am J Addict Am Addict. 2009;18(4):316–320. doi:https://doi.org/10.1080/10550490902925490.
- Guydish J, Passalacqua E, Tajima B, Chan M, Chun J, Bostrom A. Smoking prevalence in addiction treatment: a review. Nicotine Tob Res. 2011;13(6):401–411. doi:https://doi.org/10.1093/ntr/ntr048.
- Pajusco B, Chiamulera C, Quaglio G, et al. Tobacco addiction and smoking status in heroin addicts under methadone vs. buprenorphine therapy. IJERPH. 2012;9(3):932–942. doi:https://doi.org/10.3390/ijerph9030932.
- Jamison RN, Stetson BA, Parris WC. The relationship between cigarette smoking and chronic low back pain. Addict Behav. 1991;16(3-4):103–110. doi:https://doi.org/10.1016/0306-4603(91)90002-Y.
- Michna E, Ross EL, Hynes WL, et al. Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history. J Pain Symptom Manage. 2004;28(3):250–258. doi:https://doi.org/10.1016/j.jpainsymman.2004.04.007.
- LaRowe LR, Zvolensky MJ, Ditre JW. The role of anxiety-relevant transdiagnostic factors in comorbid chronic pain and tobacco cigarette smoking. Cogn Ther Res. 2019;43(1):102–113. doi:https://doi.org/10.1007/s10608-018-9957-y.
- Adrian M, Barry SJ. Physical and mental health problems associated with the use of alcohol and drugs. Subst Use Misuse. 2003;38(11-13):1575–1614. doi:https://doi.org/10.1081/JA-120024230.
- Franceschi S, Talamini R, Barra S, et al. Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy. Cancer Res. 1990;50(20):6502–6507.
- Garey L, Rogers AH, Manning K, et al. Effects of smoking cessation treatment attendance on abstinence: the moderating role of psychologically based behavioral health conditions. J Subst Abuse Treat. 2019;109:1–7. doi:https://doi.org/10.1016/j.jsat.2019.10.006.
- Grant BF, Hasin DS, Blanco C, et al. The epidemiology of social anxiety disorder in the United States: results from the National Epidemiologic Survey on alcohol and related conditions. J Clin Psychiatry. 2005;66(11):1351–1361.
- Piazza PV, Deroche-Gamonet V. A multistep general theory of transition to addiction. Psychopharmacology (Berl). 2013;229(3):387–413. doi:https://doi.org/10.1007/s00213-013-3224-4.
- Ditre JW, Zale EL, LaRowe LR. A reciprocal model of pain and substance use: transdiagnostic considerations, clinical implications, and future directions. Annu Rev Clin Psychol. 2019;15(1):503–528. doi:https://doi.org/10.1146/annurev-clinpsy-050718-095440.
- Koob GF. Neurobiology of opioid addiction: opponent process, hyperkatifeia, and negative reinforcement. Biol Psychiatry. 2019;87(1):44–53. doi:https://doi.org/10.1016/j.biopsych.2019.05.023.
- Zale EL, Maisto SA, Ditre JW. Anxiety and depression in bidirectional relations between pain and smoking: implications for smoking cessation. Behav Modif. 2016;40(1-2):7–28. doi:https://doi.org/10.1177/0145445515610744.
- Butler SF, Budman SH, Fernandez KC, et al. Development and validation of the current opioid misuse measure. Pain. 2007;130(1):144–156. doi:https://doi.org/10.1016/j.pain.2007.01.014.
- WHO ASSIST Working Group. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addict Abingdon Engl. 2002;97(9):1183–1194. doi:https://doi.org/10.1046/j.1360-0443.2002.00185.x.
- Kroenke K, Spitzer RL, Williams J. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41(11):1284–1292. doi:https://doi.org/10.1097/01.MLR.0000093487.78664.3C.
- Löwe B, Kroenke K, Gräfe K. Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res. 2005;58(2):163–171. doi:https://doi.org/10.1016/j.jpsychores.2004.09.006.
- Löwe B, Wahl I, Rose M, et al. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord. 2010;122(1-2):86–95. doi:https://doi.org/10.1016/j.jad.2009.06.019.
- Wasan AD, Butler SF, Budman SH, Benoit C, Fernandez K, Jamison RN. Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain. Clin J Pain. 2007;23(4):307–315. doi:https://doi.org/10.1097/AJP.0b013e3180330dc5.
- Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain. 1992;50(2):133–149. doi:https://doi.org/10.1016/0304-3959(92)90154-4.
- Shapiro DN, Chandler J, Mueller PA. Using mechanical Turk to study clinical populations. Clin Psychol Sci. 2013;1(2):213–220. doi:https://doi.org/10.1177/2167702612469015.
- Koechl B, Unger A, Fischer G. Age-related aspects of addiction. Gerontology. 2012;58(6):540–544. doi:https://doi.org/10.1159/000339095.
- Brady KT, Randall CL. Gender differences in substance use disorders. Psychiatr Clin North Am. 1999;22(2):241–252. doi:https://doi.org/10.1016/S0193-953X(05)70074-5.
- Jamison RN, Link CL, Marceau LD. Do pain patients at high risk for substance misuse experience more pain? A longitudinal outcomes study. Pain Med. 2009;10(6):1084–1094. doi:https://doi.org/10.1111/j.1526-4637.2009.00679.x.
- Sedgwick P. Multiple significance tests: the Bonferroni correction. BMJ. 2012;344(jan25 4):e509–e509. doi:https://doi.org/10.1136/bmj.e509.
- Ditre JW, Brandon TH, Zale EL, Meagher MM. Pain, nicotine, and smoking: research findings and mechanistic considerations. Psychol Bull. 2011;137(6):1065–1093. doi:https://doi.org/10.1037/a0025544.
- Ekholm O, Grønbaek M, Peuckmann V, Sjøgren P. Alcohol and smoking behavior in chronic pain patients: the role of opioids. Eur J Pain. 2009;13(6):606–612. doi:https://doi.org/10.1016/j.ejpain.2008.07.006.
- Hedden SL, Martins SS, Malcolm RJ, Floyd L, Cavanaugh CE, Latimer WW. Patterns of illegal drug use among an adult alcohol dependent population: results from the National Survey on Drug Use and Health. Drug Alcohol Depend. 2010;106(2-3):119–125. doi:https://doi.org/10.1016/j.drugalcdep.2009.08.002.
- White A, Chan GC, Quek L-H, et al. The topography of multiple drug use among adolescent Australians: findings from the National Drug Strategy Household Survey. Addict Behav. 2013;38(4):2068–2073. doi:https://doi.org/10.1016/j.addbeh.2013.01.001.
- Rogers AH, Bakhshaie J, Orr MF, Ditre JW, Zvolensky MJ. Health literacy, opioid misuse, and pain experience among adults with chronic pain. Pain Med. 2019. doi:https://doi.org/10.1093/pm/pnz062. [Epub ahead of print].
- Edwards RR, Wasan AD, Michna E, Greenbaum S, Ross E, Jamison RN. Elevated pain sensitivity in chronic pain patients at risk for opioid misuse. J Pain. 2011;12(9):953–963. doi:https://doi.org/10.1016/j.jpain.2011.02.357.
- Martel MO, Dolman AJ, Edwards RR, Jamison RN, Wasan AD. The association between negative affect and prescription opioid misuse in patients with chronic pain: the mediating role of opioid craving. J Pain. 2014;15(1):90–100. doi:https://doi.org/10.1016/j.jpain.2013.09.014.
- Martel MO, Wasan AD, Jamison RN, Edwards RR. Catastrophic thinking and increased risk for prescription opioid misuse in patients with chronic pain. Drug Alcohol Depend. 2013;132(1-2):335–341. doi:https://doi.org/10.1016/j.drugalcdep.2013.02.034.
- Handford C, Kahan M, Lester MD, Ordean A. Buprenorphine/Naloxone for Opioid Dependence: Clinical Practice Guideline. Toronto, Canada: Centre for Addiction and Mental Health; 2012.
- World Health Organization. Principles of Drug Dependence Treatment. Discussion Paper. Management of Substance Abuse. https://www.who.int/substance_abuse/publications/principles_drug_dependence_treatment.pdf?ua=1. Published 2008.
- Kathryn McHugh R, Otto MW. Profiles of distress intolerance in a substance-dependent sample. Am J Drug Alcohol Abuse. 2012;38(2):161–165. doi:https://doi.org/10.3109/00952990.2011.643990.
- Reips U-D. Privacy and the Disclosure of Information on the Internet: Issues and Measurement. Warsaw: UKSW Publishing House. 2011:71–104.
- Fleming MF, Balousek SL, Klessig CL, Mundt MP, Brown DD. Substance use disorders in a primary care sample receiving daily opioid therapy. J Pain. 2007;8(7):573–582. doi:https://doi.org/10.1016/j.jpain.2007.02.432.
- Saunders KW, Von Korff M, Campbell CI, et al. Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors. J Pain. 2012;13(3):266–275. doi:https://doi.org/10.1016/j.jpain.2011.11.004.
- King SA, Strain JJ. Benzodiazepine use by chronic pain patients. Clin J Pain. 1990;6(2):143–147. doi:https://doi.org/10.1097/00002508-199006000-00013.
- Hogarth L, Balleine BW, Corbit LH, Killcross S. Associative learning mechanisms underpinning the transition from recreational drug use to addiction. Annals of the New York Academy of Sciences. 2012;1(1282):12–24. doi:https://doi.org/10.1111/j.1749-6632.2012.06768.x.
- Reich T, Edenberg HJ, Goate A, et al. Genome‐wide search for genes affecting the risk for alcohol dependence. Am J Med Genet. 1998;81(3):207–215. doi:https://doi.org/10.1002/(SICI)1096-8628(19980508)81:3<207::AID-AJMG1>3.0.CO;2-T.
- Boyd CJ, Esteban McCabe S, Teter CJ. Medical and nonmedical use of prescription pain medication by youth in a Detroit-area public school district. Drug Alcohol Depend. 2006;81(1):37–45. doi:https://doi.org/10.1016/j.drugalcdep.2005.05.017.